APP and Alzheimer disease: When chronic cerebral hypoperfusion was induced in mouse models of Alzheimer’s disease, represented by mice overexpressing a mutant form of the human amyloid precursor protein bearing both the Swedish and Indiana mutations (APP (Sw/Ind)-Tg mice), it was found that the coagulability of the amyloid protein was enhanced.